Grape King Bio Overview
- Year Founded
-
1969
- Status
-
Public
- Employees
-
501
- Stock Symbol
-
1707
- Share Price
-
$4.20
- (As of Friday Closing)
Grape King Bio General Information
Description
Grape King Bio Ltd is a specialty and generic drug manufacturing company engaged in producing and selling pharmaceutical preparations, patent medicine, liquid tonic, drink, and healthy food. The company has three segments: MLM (Multi-Level Marketing) is a direct seller of Pro-partner Inc, including the company's development and manufacturing products for Pro-partner Inc, Distributors segment includes the company's self-owned brand products, and ODM/OEM (Original Design Manufacturer/Original Equipment Manufacturer) includes ODM/OEM in Taiwan and Shanghai. The group operates in three principal geographical areas - Taiwan, China, and Others, and it derives a majority of its revenue from Taiwan.
Contact Information
Website
www.grapeking.com.twCorporate Office
- 342 Number 402, Section 2, Jinling Road
- Pingzhen District
- Taoyuan
- Taiwan
Corporate Office
- 342 Number 402, Section 2, Jinling Road
- Pingzhen District
- Taoyuan
- Taiwan
Grape King Bio Stock Performance
As of 25-Apr-2025, Grape King Bio’s stock price is $4.20. Its current market cap is $623M with 148M shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $4.20 | $4.22 | $3.84 - $5.05 | $623M | 148M | 198K | $0.30 |
Grape King Bio Financials Summary
As of 31-Dec-2024, Grape King Bio has a trailing 12-month revenue of $348M.
|
In Thousands, USD |
TTM 31-Dec-2024 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 | FY 2022 31-Dec-2022 |
|---|---|---|---|---|
| EV | 619,724 | 619,724 | 690,780 | 754,313 |
| Revenue | 347,766 | 347,766 | 341,449 | 349,036 |
| EBITDA | 97,844 | 97,844 | 98,732 | 104,798 |
| Net Income | 45,132 | 45,132 | 46,639 | 48,944 |
| Total Assets | 465,991 | 465,991 | 504,811 | 490,683 |
| Total Debt | 4,893 | 4,893 | 6,278 | 5,142 |
Grape King Bio Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Grape King Bio Patents
Grape King Bio Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| JP-2024155659-A | Clostridium butyricum gkb7-containing composition for ameliorating osteoarthritis or degenerative arthritis | Active | 19-Apr-2023 | ||
| AU-2023266299-A1 | Anti-fatigue lactobacillus composition and use thereof | Pending | 12-Apr-2023 | ||
| JP-2024152571-A | Anti-fatigue composition containing lactobacillus | Active | 12-Apr-2023 | ||
| US-20240342229-A1 | Anti-fatigue lactobacillus composition and method of promoting anti-fatigue performance after aerobic exercise of subject in need thereof by using the same | Pending | 12-Apr-2023 | ||
| JP-2024143958-A | Composition for improving exercise performance and reducing exercise fatigue, containing extract of phellinus linteus gkpl | Pending | 28-Mar-2023 | A61K36/07 |
Grape King Bio Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Grape King Bio Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Grape King Bio ESG
Risk Overview
Risk Rating
Updated November, 22, 2024
21.34 | Med Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 15,109
Rank
Percentile
Household Products
Industry
of 104
Rank
Percentile
Personal Products
Subindustry
of 81
Rank
Percentile
Grape King Bio FAQs
-
When was Grape King Bio founded?
Grape King Bio was founded in 1969.
-
Where is Grape King Bio headquartered?
Grape King Bio is headquartered in Taoyuan, Taiwan.
-
What is the size of Grape King Bio?
Grape King Bio has 501 total employees.
-
What industry is Grape King Bio in?
Grape King Bio’s primary industry is Biotechnology.
-
Is Grape King Bio a private or public company?
Grape King Bio is a Public company.
-
What is Grape King Bio’s stock symbol?
The ticker symbol for Grape King Bio is 1707.
-
What is the current stock price of Grape King Bio?
As of 25-Apr-2025 the stock price of Grape King Bio is $4.20.
-
What is the current market cap of Grape King Bio?
The current market capitalization of Grape King Bio is $623M.
-
What is Grape King Bio’s current revenue?
The trailing twelve month revenue for Grape King Bio is $348M.
-
What is Grape King Bio’s annual earnings per share (EPS)?
Grape King Bio’s EPS for 12 months was $0.30.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
